Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AKTS
PCRX
Add up to 3 more stocks
AKTS
Aktis Oncology, Inc.
-3.56%
$17.86-0.66Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$953.81M
52W Range
$14.72 - $34.19
PCRX
Pacira BioSciences, Inc.
-1.16%
$24.76-0.29Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$973.93M
52W Range
$18.80 - $27.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 70.48 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.97 | 1.45 |
| P/S Ratio | 94.81 | 1.31 |
| P/FCF Ratio | N/A | 5.43 |
| EV/EBITDA | N/A | 11.39 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 79.2% |
| Operating Margin | -1149.5% | 2.5% |
| Net Margin | -727.0% | 2.0% |
| ROE | -15.1% | 2.2% |
| ROA | -13.1% | 1.2% |
| ROIC | -16.5% | 1.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.33 | 5.04 |
| Quick Ratio | 16.33 | 3.94 |
| Debt/Equity | 0.02 | 0.61 |
| Interest Coverage | N/A | 2.28 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.